APA (7th ed.) Citation

SV, J., & NS, R. (2015). Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies? Dove Medical Press.

Chicago Style (17th ed.) Citation

SV, Janardhan, and Reau NS. Should NS5A Inhibitors Serve as the Scaffold for All-oral Anti-HCV Combination Therapies? Dove Medical Press, 2015.

MLA (8th ed.) Citation

SV, Janardhan, and Reau NS. Should NS5A Inhibitors Serve as the Scaffold for All-oral Anti-HCV Combination Therapies? Dove Medical Press, 2015.